Entity Common Stock, Shares Outstanding of PLUS THERAPEUTICS, INC. from Q2 2011 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
PLUS THERAPEUTICS, INC. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q2 2011 to Q3 2025.
  • PLUS THERAPEUTICS, INC. Entity Common Stock, Shares Outstanding for the quarter ending 29 Oct 2025 was 137M shares, a 2231% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

PLUS THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 137M +132M +2231% 29 Oct 2025 10-Q 30 Oct 2025
Q2 2025 32.7M +26.8M +455% 27 May 2025 10-Q 30 May 2025
Q1 2025 17M +12.7M +298% 21 Mar 2025 10-K 31 Mar 2025
Q3 2024 5.9M +1.37M +30.4% 07 Nov 2024 10-Q 14 Nov 2024
Q2 2024 5.9M +3.02M +105% 09 Aug 2024 10-Q 14 Aug 2024
Q1 2024 4.28M -32.4M -88.3% 26 Feb 2024 10-K 05 Mar 2024
Q3 2023 4.52M -29.1M -86.5% 25 Oct 2023 10-Q 31 Oct 2023
Q2 2023 2.88M -19.7M -87.2% 07 Aug 2023 10-Q 14 Aug 2023
Q1 2023 36.7M +14.5M +65.3% 18 Apr 2023 10-Q 20 Apr 2023
Q3 2022 33.6M +18.2M +119% 14 Oct 2022 10-Q 20 Oct 2022
Q2 2022 22.5M +10.4M +86.4% 14 Jul 2022 10-Q 21 Jul 2022
Q1 2022 22.2M +1.09M +5.17% 14 Apr 2022 10-Q 21 Apr 2022
Q3 2021 15.4M +10.6M +221% 15 Oct 2021 10-Q 21 Oct 2021
Q2 2021 12.1M +7.81M +183% 19 Jul 2021 10-Q 22 Jul 2021
Q1 2021 21.1M +17.2M +444% 09 Apr 2021 10-Q 22 Apr 2021
Q3 2020 4.78M +1.01M +26.8% 14 Oct 2020 10-Q 22 Oct 2020
Q2 2020 4.27M +3.82M +843% 03 Aug 2020 10-Q 10 Aug 2020
Q1 2020 3.88M -18.3M -82.5% 20 Mar 2020 10-K 30 Mar 2020
Q3 2019 3.77M -9.43M -71.4% 08 Nov 2019 10-Q 14 Nov 2019
Q2 2019 453K -7.25M -94.1% 31 Jul 2019 10-Q 15 Aug 2019
Q1 2019 22.2M -39.5M -64% 30 Apr 2019 10-Q 14 May 2019
Q4 2018 16.3M -43.5M -72.7% 31 Jan 2019 10-K 29 Mar 2019
Q3 2018 13.2M -21.9M -62.4% 31 Oct 2018 10-Q 14 Nov 2018
Q2 2018 7.71M -27M -77.8% 31 Jul 2018 10-Q 14 Aug 2018
Q1 2018 61.6M +29.1M +89.7% 30 Apr 2018 10-Q 11 May 2018
Q4 2017 59.8M +37.9M +172% 31 Jan 2018 10-K 09 Mar 2018
Q3 2017 35.1M +14.6M +71.3% 31 Oct 2017 10-Q 09 Nov 2017
Q2 2017 34.7M +14.2M +69.4% 01 Aug 2017 10-Q 11 Aug 2017
Q1 2017 32.5M +19.1M +144% 30 Apr 2017 10-Q 12 May 2017
Q4 2016 22M -173M -88.7% 31 Jan 2017 10-K 24 Mar 2017
Q3 2016 20.5M -138M -87.1% 31 Oct 2016 10-Q 09 Nov 2016
Q2 2016 20.5M -130M -86.4% 31 Jul 2016 10-Q 05 Aug 2016
Q1 2016 13.3M -112M -89.4% 15 Apr 2016 10-Q 10 May 2016
Q4 2015 195M 31 Jan 2016 10-K 11 Mar 2016
Q3 2015 158M +66M +71.4% 31 Oct 2015 10-Q 06 Nov 2015
Q2 2015 151M +71.4M +89.8% 31 Jul 2015 10-Q 10 Aug 2015
Q1 2015 126M +50.3M +66.7% 30 Apr 2015 10-Q 11 May 2015
Q3 2014 92.4M +25.2M +37.4% 31 Oct 2014 10-Q 07 Nov 2014
Q2 2014 79.5M +12.3M +18.3% 31 Jul 2014 10-Q 11 Aug 2014
Q1 2014 75.5M +8.28M +12.3% 30 Apr 2014 10-Q 12 May 2014
Q3 2013 67.3M +8.44M +14.3% 31 Oct 2013 10-Q 12 Nov 2013
Q2 2013 67.2M +8.52M +14.5% 31 Jul 2013 10-Q 09 Aug 2013
Q1 2013 67.2M +8.5M +14.5% 30 Apr 2013 10-Q 10 May 2013
Q3 2012 58.8M +3.5M +6.32% 31 Oct 2012 10-Q 09 Nov 2012
Q2 2012 58.7M +4.91M +9.14% 31 Jul 2012 10-Q 09 Aug 2012
Q1 2012 58.7M 30 Apr 2012 10-Q 10 May 2012
Q3 2011 55.3M 31 Oct 2011 10-Q 08 Nov 2011
Q2 2011 53.8M 29 Jul 2011 10-Q 09 Aug 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.